PRESS RELEASE published on 07/02/2024 at 19:28, 1 year 11 months ago Marie Brizard Wine & Spirits_Half-year review of Marie Brizard Wine & Spirits’ liquidity contract Marie Brizard Wine & Spirits provides a half-year review of its liquidity contract with Natixis Oddo BHF, detailing assets and transactions. For more details, contact Investor Relations & Shareholders or Media Liquidity Contract NATIXIS ODDO BHF Investor Relations Share Transactions Marie Brizard Wine & Spirits
BRIEF published on 06/06/2024 at 14:39, 2 years ago Marie Brizard Wine & Spirits : Mise à disposition des documents préparatoires à l'Assemblée générale du 27 juin 2024 Actionnaires Assemblée Générale 2024 Documents Préparatoires Marie Brizard Wine & Spirits
BRIEF published on 06/06/2024 at 14:39, 2 years ago Marie Brizard Wine & Spirits: Availability of preparatory documents for the General Meeting of June 27, 2024 Shareholders 2024 General Assembly Preparatory Documents Marie Brizard Wine & Spirits
PRESS RELEASE published on 06/06/2024 at 14:34, 2 years ago Marie Brizard Wine & Spirits Mise à disposition des documents préparatoires à l'Assemblée générale du 27 juin 2024 Marie Brizard Wine & Spirits annonce la mise à disposition des documents préparatoires pour son Assemblée Générale du 27 juin 2024 Actionnaires Assemblée Générale Documents Préparatoires Ordre Du Jour Marie Brizard Wine & Spirits
Published on 06/29/2026 at 15:00, 52 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 52 minutes ago Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 14:30, 1 hour 22 minutes ago Unusual Machines Added to Russell 2000(R) Index
Published on 06/29/2026 at 14:30, 1 hour 22 minutes ago Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web
Published on 06/29/2026 at 14:30, 1 hour 22 minutes ago US FDA Has Granted A "Rare Pediatric Disease Drug" Designation for NV-387 As A Treatment for Measles - Enables Priority Review Voucher
Published on 06/29/2026 at 15:34, 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/29/2026 at 15:30, 21 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Published on 06/29/2026 at 10:56, 4 hours 55 minutes ago GUILLEMOT CORPORATION S.A. | Déclaration hebdomadaire des transactions sur actions propres du 22 au 26 juin 2026
Published on 06/29/2026 at 10:56, 4 hours 55 minutes ago GUILLEMOT CORPORATION S.A. | Weekly report share buyback from June 22 to June 26 2026
